Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
Study NCT ID:
NCT03269695
Status:
TERMINATED
Last Update Posted:
2021-12-28
First Post:
2017-08-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-30
First Submit QC Date:
None
Study First Post Date:
2017-09-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-06
Results First Submit QC Date:
None
Results First Post Date:
2021-12-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-29
Last Update Post Date:
2021-12-28
Last Update Post Date Type:
ACTUAL